ARPA-H has launched EVIDENT, a $100M program to build quantitative measurement systems and data infrastructure for mental health, linking rapid-acting treatments to objective, longitudinal clinical evidence.

UNESCO has adopted the first global neurotechnology ethics standard, treating neural data as sensitive, banning sleep-based manipulation, and setting strict limits for workplace and classroom use as neurotech enters consumer products.

As neurotechnology moves into consumer markets, U.S. lawmakers are proposing new protections for brain-derived data, signaling a shift in how neural signals are treated under privacy law.

China is moving to industrialise brain–computer interfaces at a national scale, combining state funding, coordinated regulation, and parallel clinical development in an effort to compete with U.S.-led neurotech ecosystems.